Literature DB >> 22990039

Levetiracetam-associated aggravation of myoclonic seizure in children.

Yong-Hong Liu1, Xiao-Li Wang, Yan-Chun Deng, Gang Zhao.   

Abstract

Some antiepileptic drugs (AEDs) have been reported to aggravate generalized seizures. We have seen three children whose myoclonic seizures increased on starting treatment with Levetiracetam. In all seizures aggravation was temporally associated to the introduction of the drug. All became seizure-free on withdrawal of levetiracetam with a switch to an alternative antiepileptic drug and this persisted for at least 6 months. This suggests that some children with myoclonic seizures may have an aggravation on starting treatment with levetiracetam but this requires further studies.
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990039     DOI: 10.1016/j.seizure.2012.08.008

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  1 in total

Review 1.  Clinical pharmacology and pharmacokinetics of levetiracetam.

Authors:  Chanin Wright; Jana Downing; Diana Mungall; Owais Khan; Amanda Williams; Ekokobe Fonkem; Darin Garrett; Jose Aceves; Batool Kirmani
Journal:  Front Neurol       Date:  2013-12-04       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.